How Does Cannabis Influence Arousal Threshold in Sleep Apnoea?

PostedMarch 5, 2026

UpdatedMarch 5, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

The arousal threshold refers to the sensitivity of a patient to awakenings during apnoea events. Understanding the impact of cannabis on arousal threshold is essential for managing sleep fragmentation and improving overall sleep quality in sleep apnoea patients.

Cannabis and Sleep Arousal

Evidence suggests that the impact of cannabis on arousal threshold may modulate how easily patients awaken during airway obstruction. This has potential benefits for reducing unnecessary sleep interruptions while maintaining safety during apnoea episodes.

Raising Arousal Threshold

Cannabis may increase the arousal response in OSA threshold, allowing patients to remain in deeper sleep stages longer, which could reduce the number of awakenings per night.

Preventing Over-Sedation

While raising the arousal threshold, careful monitoring is needed to avoid excessive sedation. Balancing the sleep fragmentation with cannabinoids ensures airway safety and overall sleep stability.

Clinical Implications

The modulation of arousal response in OSA can directly affect the severity of apnoea events. By influencing the impact of cannabis on arousal threshold, therapy may be optimised to maintain restorative sleep without compromising breathing.

The impact of cannabis on arousal threshold represents a promising area in sleep apnoea management. Early studies show modulation of arousal response in OSA and potential reduction in sleep fragmentation with cannabinoids, though more clinical research is needed to establish guidelines for safe and effective use.

If you’re exploring cannabis treatment options for obstructive sleep apnoea, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obstructive Sleep Apnoea.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.